Replies to post #71151 on Biotech Values

[DewDiligence]

Re: ANDS / ANA598

Yes on all counts. However, the consequential viral-rebound data won’t be available until phase-2, when ANA598 is tested with peg-ifn and ribavirin.

Note the rationale for the 3-day limit of the phase-1b study in the header of #msg-34678306.